KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Depreciation & Amortization (CF): 2010-2025

Historic Depreciation & Amortization (CF) for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to $196,000.

  • Nektar Therapeutics' Depreciation & Amortization (CF) fell 80.26% to $196,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 79.55%. This contributed to the annual value of $4.4 million for FY2024, which is 43.81% down from last year.
  • Per Nektar Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $196,000 for Q3 2025, which was down 8.41% from $214,000 recorded in Q2 2025.
  • Nektar Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $3.7 million during Q1 2022, with a 5-year trough of $196,000 in Q3 2025.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $1.5 million (2024), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Depreciation & Amortization (CF) increased by 11.56% in 2021, and later crashed by 85.33% in 2025.
  • Over the past 5 years, Nektar Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $3.4 million in 2021, then dropped by 7.39% to $3.2 million in 2022, then crashed by 48.08% to $1.7 million in 2023, then crashed by 79.90% to $332,000 in 2024, then plummeted by 80.26% to $196,000 in 2025.
  • Its Depreciation & Amortization (CF) was $196,000 in Q3 2025, compared to $214,000 in Q2 2025 and $426,000 in Q1 2025.